Ev » Tüm » Hisse Tahmini » Viridian Therapeutics Inc. Common Stock Tahmin etmek

Viridian Therapeutics Inc. Common Stock Tahmin etmek: Yarın, Hafta, Ay, 5 Yıl

Güncellendi: April 22 · 2026 at 07:03 UTC

From

▼ -2.73%Market Cap $1.47B · Technical analysis Bearish · Focus area Price + volatility

Tahmin Özeti

Zaman aralığı	Tahmini Fiyat	Geçmiş	Tarihsel	İç yüzü
Yarın	$14.44 ▲ +1.15%	Dün	$14.21 ▼ -0.48%	Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%.
Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%.
Hafta	$14.79 ▲ +3.58%	Geçen hafta	$14.07 ▼ -1.50%	The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick.
The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick.
Ay	$15.37 ▲ +7.61%	Geçen ay	$13.82 ▼ -3.20%	The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Yıl	$16.23 ▲ +13.67%	Geçen sene	$13.46 ▼ -5.74%	The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Yıl	$18.26 ▲ +27.86%	5 Yıl Önce	$12.61 ▼ -11.70%	The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Yarın$14.44▲ +1.15%

Dün$14.21▼ -0.48%

Tomorrow's Viridian Therapeutics Inc. Common Stock (VRDN) setup is anchored to $14.28 and targets $14.44 (+1.15%). The near-term read is upside; watch $14.71 / $13.85 because daily realized volatility is about 5.93%.

Hafta$14.79▲ +3.58%

Geçen hafta$14.07▼ -1.50%

The 7-day Viridian Therapeutics Inc. Common Stock model moves from $14.07 to $14.79 (+3.58%). It gives upside momentum context for this stock, so breaks around $14.71 / $13.85 matter more than a single tick.

Ay$15.37▲ +7.61%

Geçen ay$13.82▼ -3.20%

The 1-month Viridian Therapeutics Inc. Common Stock target is $15.37 (+7.61%), compared with the live reference near $14.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Yıl$16.23▲ +13.67%

Geçen sene$13.46▼ -5.74%

The 1-year Viridian Therapeutics Inc. Common Stock scenario points to $16.23 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Yıl$18.26▲ +27.86%

5 Yıl Önce$12.61▼ -11.70%

The 5-year Viridian Therapeutics Inc. Common Stock view is $18.26 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Fiyat Tablosu

TarihselTahmin etmekYükselişdüşüş eğilimi

Teknik Analiz

Neutral

Yükseliş

Doğal

düşüş eğilimi

Temel Göstergeler

Gösterge	Değer	Sinyal
Price	$14.28	Mid
Daily Change	-2.73%	Below
Volatility Cap	20.0%	Mid
Confidence	63%	Above
Data Source	nasdaq-screener	Mid

Geçmiş Veriler

Current$14.28

Daily Change-2.73%

Market Cap$1.47B

Sourcenasdaq-screener

Current	$14.28	Daily Change	-2.73%
Market Cap	$1.47B	Source	nasdaq-screener

Destek ve Direnç Seviyeleri

$13.85Support 1

$14.28Akım

$14.71Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Fiyat Aşamaları

Anahtar seviyeler ve tarihsel bağlam

Current$14.28Live reference price

Used as the anchor for generated forecast calculations.

Next Month$15.37Model projection+7.61%

Directional scenario based on capped drift.

Tahmin Doğruluğu

Modelimizin performansı nasıl?

63%

Yönlü

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Algoritmamız, en son fiyat hareketi, oynaklık rejimi ve gösterge sinyalleri kullanılarak haftalık olarak yeniden kalibre edilir. Doğruluk zaman dilimine göre değişir; kısa vadeli momentum, uzun vadeli tahminlerden daha güvenilirdir.

Short term

63%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Yatırım Senaryoları

Bugün $1,000'yu VRDN'ya yatırırsanız

Bullish Scenario

$14.99

+5.00% from current

Hedef Fiyat$14.99

SenaryoUpside momentum

Olasılık55%

Base Scenario

$15.37

+7.61%

Hedef Fiyat$15.37

SenaryoCapped drift

Olasılık63%

Bearish Scenario

$13.57

-5.00% from current

Hedef Fiyat$13.57

SenaryoVolatility drawdown

Olasılık37%

Temel: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Tahmin Faktörleri

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 66/100

24H drift+1.15%

7D drift+3.58%

30D drift+7.61%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 64/100

1M outlook+7.61%

1Y outlook+13.67%

5Y outlook+27.86%

Sıkça Sorulan Sorular

Q What is the Viridian Therapeutics Inc. Common Stock (VRDN) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Viridian Therapeutics Inc. Common Stock is projected near $14.44 versus the current reference around $14.28. That implies a modeled move of +1.15% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for VRDN?

The weekly Viridian Therapeutics Inc. Common Stock model points to $14.79, which maps to an expected drift of +3.58% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Viridian Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Viridian Therapeutics Inc. Common Stock 1-month target is $15.37 (+7.61%), while the 1-year target is $16.23 (+13.67%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Viridian Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Viridian Therapeutics Inc. Common Stock long-horizon scenario sits near $18.26 with a modeled change of +27.86%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are VRDN support and resistance zones right now?

For Viridian Therapeutics Inc. Common Stock, nearest resistance is around $13.85, while nearest support is around $14.71. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Viridian Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.